Sunshine Biopharma Inc expected to post a loss of $8.00 a share - Earnings Preview

Sunshine Biopharma

07/05/2024 12:08

* Sunshine Biopharma Inc  SBFM.OQ   SBFM.O  is expected
to report
resultson May 9 (estimated) for the period ending March 31 2024
    * The Pointe-claire Quebec-based  company is expected to
report
revenue of $7 million, according to the estimate from one
analyst, based on LSEG data.
    * ​LSEG's mean analyst estimate for Sunshine Biopharma Inc
is for
a loss of $8.00 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sunshine
Biopharma Inc is $300.00​, above​ its last closing price
of $0.99. ​​​

This summary was machine generated May 7 at 11:08 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)